Insider Trades19 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Sell | HROW | Amir Shojaei | CHIEF SCIENTIFIC OFFICER | 22,500 | $37.98 | $1.3B | -37.14% | +20.81% | $854.5K | +0.00% | — | Stalk |
| May 14, 2026 | Buy | HROW | Andrew R. Boll | PRESIDENT AND CFO | 3,500 | $29.90 | $1.3B | -37.14% | +20.81% | $104.7K | +0.43% | — | Stalk |
| May 14, 2026 | Buy | HROW | Mark L Baum | CHIEF EXECUTIVE OFFICER | 10,000 | $30.20 | $1.3B | -37.14% | +20.81% | $302.0K | +0.33% | — | Stalk |
| Dec 12, 2025 | Buy | HROW | Andrew R. Boll | PRESIDENT AND CFO | 86,665 | $17.21 | $1.3B | -37.14% | +20.81% | $1.5M | +2.06% | — | Stalk |
| Dec 12, 2025 | Buy | HROW | Mark L Baum | CHIEF EXECUTIVE OFFICER | 259,994 | $17.21 | $1.3B | -37.14% | +20.81% | $4.5M | +1.68% | — | Stalk |
| Jul 21, 2025 | Buy | HROW | Mark L Baum | CHIEF EXECUTIVE OFFICER | 913,338 | $17.89 | $1.3B | -37.14% | +20.81% | $16.3M | +4.94% | — | Stalk |
| Apr 7, 2025 | Sell | HROW | John P. Saharek | CEO & President, ImprimisRx | 109,475 | $23.09 | $1.3B | -37.14% | +20.81% | $2.5M | -18.98% | — | Stalk |
| Apr 7, 2025 | Sell | HROW | Andrew R. Boll | Chief Financial Officer | 136,745 | $23.09 | $1.3B | -37.14% | +20.81% | $3.2M | -14.95% | — | Stalk |
| Apr 7, 2025 | Sell | HROW | Mark L Baum | Chief Executive Officer | 300,363 | $23.09 | $1.3B | -37.14% | +20.81% | $6.9M | -10.36% | — | Stalk |
| Sep 11, 2024 | Buy | HROW | John P. Saharek | CEO of ImprimisRx | 135,140 | $18.73 | $1.3B | -37.14% | +20.81% | $2.5M | +7.48% | — | Stalk |
| Mar 22, 2024 | Buy | HROW | Mark L Baum | CHIEF EXECUTIVE OFFICER | 9,000 | $11.59 | $1.3B | -37.14% | +20.81% | $104.3K | +0.42% | — | Stalk |
| Mar 1, 2024 | Buy | HROW | John P. Saharek | CEO of ImprimisRx | 5,000 | $8.75 | $1.3B | -37.14% | +20.81% | $43.8K | +2.00% | — | Stalk |
| Feb 20, 2024 | Buy | HROW | John P. Saharek | CEO of ImprimisRx | 42,616 | $10.67 | $1.3B | -37.14% | +20.81% | $454.7K | +9.07% | — | Stalk |
| Feb 20, 2024 | Buy | HROW | Andrew R. Boll | CHIEF FINANCIAL OFFICER | 63,480 | $10.67 | $1.3B | -37.14% | +20.81% | $677.3K | +5.82% | — | Stalk |
| Feb 20, 2024 | Buy | HROW | Mark L Baum | CHIEF EXECUTIVE OFFICER | 209,836 | $10.67 | $1.3B | -37.14% | +20.81% | $2.2M | +5.11% | — | Stalk |
| Feb 7, 2024 | Buy | HROW | Andrew R. Boll | CHIEF FINANCIAL OFFICER | 7,400 | $7.71 | $1.3B | -37.14% | +20.81% | $57.1K | +1.39% | — | Stalk |
| Feb 7, 2024 | Buy | HROW | Mark L Baum | CHIEF EXECUTIVE OFFICER | 15,400 | $7.71 | $1.3B | -37.14% | +20.81% | $118.7K | +0.76% | — | Stalk |
| Nov 16, 2023 | Buy | HROW | Mark L Baum | Chief Executive Officer | 7,500 | $8.11 | $1.3B | -37.14% | +20.81% | $60.8K | +0.37% | — | Stalk |
| Nov 10, 2023 | Sell | HROW | John P. Saharek | Chief Commercial Officer | 9,778 | $12.83 | $1.3B | -37.14% | +20.81% | $125.5K | -4.04% | — | Stalk |